These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 241494)

  • 1. Isolation and characterization of metabolites derived from 1-tert-butylamino-3-(2,3-dimethylphenoxy)-2-propanol (D-32), a new beta-blocker.
    Honma S; Kambekawa A
    Chem Pharm Bull (Tokyo); 1975 May; 23(5):1045-56. PubMed ID: 241494
    [No Abstract]   [Full Text] [Related]  

  • 2. [The metabolism of 1-tertiary-butylamino-3-(2,3-dimethylphenoxy)-2-propanol (D-32), a new beta-blocker agent. II. Blood level, distribution, and structure of its metabolites in bile (author's transl)].
    Honma S; Kanbekawa A
    Yakugaku Zasshi; 1975 Jun; 95(6):680-9. PubMed ID: 241825
    [No Abstract]   [Full Text] [Related]  

  • 3. [Stereoselective glucuronidation of beta-blocking agents, 1-tert-butylamino-3-(2,3-dimethylphenoxy)-2-propanol (D-32) and propranolol, in animals, in vivo and in vitro].
    Honma S; Ito T; Matsuki Y
    Yakugaku Zasshi; 1986 May; 106(5):406-13. PubMed ID: 2876088
    [No Abstract]   [Full Text] [Related]  

  • 4. Stereoselectivity in the metabolism of the beta-adrenergic blocking agent, (+/-)-1-tert-butylamino-3-(2,3-dimethylphenoxy)-2-propanol hydrochloride (xibenolol hydrochloride, D-32), in man.
    Honma S; Ito T; Kambegawa A
    Chem Pharm Bull (Tokyo); 1985 Feb; 33(2):760-8. PubMed ID: 2861914
    [No Abstract]   [Full Text] [Related]  

  • 5. [Influence of the route of administration on the metabolism of a beta-adrenergic blocker, o-[3-(tert-butylamino)-2-hydroxypropoxy]-benzonitrile (bunitrolol) (author's transl)].
    Rikihisa T; Toyama S; Mori M; Suzuki T
    Yakugaku Zasshi; 1978 Sep; 98(9):1258-66. PubMed ID: 32380
    [No Abstract]   [Full Text] [Related]  

  • 6. [Identification of urinary metabolites of befunolol in dog and man principally by mass spectrometry (author's transl)].
    Tohno M; Kimura K; Nagahara M; Sakai Y; Ofuji T; Nadai T
    Yakugaku Zasshi; 1979 Sep; 99(9):944-57. PubMed ID: 44723
    [No Abstract]   [Full Text] [Related]  

  • 7. Rapid analysis for metabolites of 11C-labelled drugs: fate of [11C]-S-4-(tert.-butylamino-2-hydroxypropoxy)-benzimidazol-2-one in the dog.
    Jones HA; Rhodes CG; Law MP; Becket JM; Clark JC; Boobis AR; Taylor GW
    J Chromatogr; 1991 Oct; 570(2):361-70. PubMed ID: 1686775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The metabolism of the beta receptor blocker talinolol in humans--relationship between structure, polarity and amount excreted].
    Oertel R; Richter K
    Pharmazie; 1995 Sep; 50(9):637-8. PubMed ID: 7480105
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolic studies on CS-359, a new beta-adrenergic blocking agent. I. Isolation and identification of the urinary metabolites of CS-359.
    Hayashi R; Okada M; Nakazawa T; Tanaka Y; Shimoji Y
    Chem Pharm Bull (Tokyo); 1975 Jun; 23(6):1173-83. PubMed ID: 241498
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolic fate of carteolol hydrochloride, (OPC-1085) VIII, a new beta-adrenergic blocking agent. Pharmacokinetic studies of carteolol in man.
    Morita S; Iinuma M; Kido M; Sakuragi S; Kohri H; Nishino H
    Arzneimittelforschung; 1977; 27(12):2380-3. PubMed ID: 23800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Studies on cardiovascular drugs. 8. Metabolism of 1-tert-butylamino-3-(o-(tetrahydrofurfuryloxy)phenoxy)-2-propanol hydrochloride (Y-6124)].
    Nakanishi M; Kato Y; Arima N
    Yakugaku Zasshi; 1972 Mar; 92(3):299-304. PubMed ID: 4403111
    [No Abstract]   [Full Text] [Related]  

  • 12. [Thin layer chromatographic determination of talinolol, propranolol and triamterene in urine: compliance evaluation of hypertensive patients].
    Molling J; Leuschner U; Meyer FP; Walther H
    Pharmazie; 1986 Apr; 41(4):301-2. PubMed ID: 2873599
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of talinolol metabolites in urine of man, dog, rat and mouse after oral administration by high-performance liquid chromatography-thermospray tandem mass spectrometry.
    Schupke H; Hempel R; Eckardt R; Kronbach T
    J Mass Spectrom; 1996 Dec; 31(12):1371-81. PubMed ID: 8990520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypotensive action of propranolol and a new beta-blocking agent, D-32 in conscious normotensive and renal hypertensive dogs.
    Himori N; Izumi A; Hiramatsu Y
    Arch Int Pharmacodyn Ther; 1976 Mar; 220(1):4-18. PubMed ID: 8021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitive gas chromatographic method for the determination in blood and urine of SL 75212 [4-(2-cyclopropylmethoxyethyl)-1-phenoxy-3-isopropylaminopropan-2-ol], a new beta 1 adrenoceptor blocking agent.
    Bianchetti G; Ganansia J; Morselli PL
    J Chromatogr; 1979 Aug; 176(1):134-9. PubMed ID: 44712
    [No Abstract]   [Full Text] [Related]  

  • 16. Rapid and sensitive high-performance liquid chromatographic determination of bisoprolol in plasma and urine.
    Poirier JM; Perez M; Cheymol G; Jaillon P
    J Chromatogr; 1988 Apr; 426(2):431-7. PubMed ID: 2899087
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification and determination of the enantiomers of moprolol and their metabolites in human urine by high-performance liquid chromatography and gas chromatography-mass spectrometry.
    Li F; Bi H; Côté M; Cooper S
    J Chromatogr; 1993 Dec; 622(2):187-95. PubMed ID: 7908669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-performance liquid chromatographic method for the determination of carvedilol and its desmethyl metabolite in body fluids.
    Reiff K
    J Chromatogr; 1987 Jan; 413():355-62. PubMed ID: 2881938
    [No Abstract]   [Full Text] [Related]  

  • 19. Simple method for routine determination of betaxolol in blood and urine by automated high-performance liquid chromatography with fluorimetric detection.
    Caqueret H; Bianchetti G
    J Chromatogr; 1984 Nov; 311(1):199-205. PubMed ID: 6151567
    [No Abstract]   [Full Text] [Related]  

  • 20. Simultaneous quantitative determination of tertatolol and its hydroxylated metabolite in human plasma and urine by gas chromatography-mass spectrometry.
    Efthymiopoulos C; Staveris S; Weber F; Koffel JC; Jung L
    J Chromatogr; 1987 Oct; 421(2):360-6. PubMed ID: 2892852
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.